(Press-News.org) Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain patients. A clinical trial published in BJU International generated promising results for a type of focal therapy, which directly targets the cancer and spares the remainder of the unaffected prostate gland.
The ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT-PC) trial is the first pivotal trial of ProFocal®, a novel, cooled laser focal therapy device for prostate cancer treatment.
In the 100-participant trial, 84% of patients had no clinically significant prostate cancer on their 3-month post-treatment biopsy. The treatment provided similar cancer-related outcomes to those that have been reported for other focal therapy devices, but with an improved safety profile and low rates of incontinence.
“This new technology is very promising with excellent cancer control while preserving patients’ quality of life,” said corresponding author Jonathan Kam, MD, of Nepean Hospital, in Australia. “Traditional radical prostatectomy and radiotherapy for prostate cancer results in very high rates of incontinence and erectile dysfunction. With this new technology, patients can have their prostate cancer treated with very low risk of suffering the side effects associated with traditional prostate cancer treatments.”
URL upon publication: https://onlinelibrary.wiley.com/doi/10.1111/bju.70150
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.
About the Journal
BJU International is one of the world’s leading urology journals. We aim to provide the very highest standard of research and clinical information for the urological community, promoting awareness of new advances and supporting best practice.
About Wiley
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.
END
Novel laser therapy device generates promising results in prostate cancer clinical trial
2026-01-28
ELSE PRESS RELEASES FROM THIS DATE:
Does screen time affect teens’ sleep and lifestyle habits?
2026-01-28
New research in Brain & Behavior found a link between screen time and adolescents’ sleep quality and beliefs about healthy lifestyles.
In the study of 700 teens attending 2 high schools in the Black Sea region of Turkey, questionnaire responses revealed that participants who spent more time exposed to screens tended to have lower sleep quality. These adolescents were also less likely to have beliefs supporting the importance of maintaining a healthy lifestyle.
Screen exposure appeared to play a mediating role in the relationship between sleep quality ...
How do native and non-native plants affect endangered plant species in cities?
2026-01-28
Research in the Journal of Applied Ecology has identified threats to endangered plants in an urban area, generating information that can be used to guide effective conservation strategies across major cities.
For the study, investigators in Germany analyzed data on 1,231 populations of 201 endangered plant species within Berlin’s Flora Protection Program. Threats were categorized and their relative importance was quantified at both population and species levels, and across habitat types.
Biological threats—especially ...
Men’s heart attack risk climbs by mid-30s, years before women
2026-01-28
Men reached 5% cardiovascular disease risk about seven years earlier than women
Coronary heart disease drove most of the gap
Risk started diverging around age 35
Earlier risk in men suggests factors beyond smoking, hypertension and diabetes alone
CHICAGO --- Men begin developing coronary heart disease — which can lead to heart attacks — years earlier than women, with differences emerging as early as the mid-30s, according to a large, long-term study led by Northwestern Medicine.
The findings, based on more than three decades of patient follow-up, suggest that heart disease prevention and screening ...
New study signals major advance in the future of precision cancer care
2026-01-28
A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that a new computational method may help researchers identify effective precision treatments for cancer more quickly and efficiently.
Precision oncology is the promising, recently developed, approach to cancer treatment in which providers shape therapies to the unique molecular profile of a patient’s tumor. Current cancer therapy depends increasingly on matching the right drug to the right patient. Large-scale studies evaluate thousands of drugs on hundreds of cancer cell lines to find genetic biological markers to predict a drug’s effectiveness. In practice, however, this data is incredibly ...
Long COVID brain fog far more common in US than India, other nations
2026-01-28
Study of 3,100 patients is first to compare long COVID brain symptoms across continents
Brain fog affected 86% of non-hospitalized U.S. patients, compared with 15% in India
Symptom patterns clustered by income level, not geography
Disparities likely reflect culture and healthcare access, not a different virus
CHICAGO --- Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study led ...
International differences exist in knowledge gaps and most common perimenopause symptoms
2026-01-28
CLEVELAND, Ohio (Jan 28, 2026)—Although perimenopause is experienced by all women regardless of race or nationality, it is not always experienced similarly. Studies comparing perimenopause symptoms across diverse cultures and geographic settings are lacking. A new study based on data from Flo, an international mobile health application, demonstrated inconsistency between perimenopause knowledge and actual symptoms experienced across diverse global populations. Study results are published online today in Menopause, the journal of The Menopause ...
Investigational blood biomarker panel may improve detection of pancreatic cancer
2026-01-28
Bottom Line: A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring CA19-9 levels alone.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Author: Kenneth S. Zaret, PhD, professor at the Perelman School of Medicine at the University of Pennsylvania.
Background: ...
AAVLINK: Potent DNA-recombination method for large cargo delivery in gene therapy
2026-01-28
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of their superior gene segmentation flexibility and robust gene reconstitution efficiency. However, their limited packaging capacity is a major challenge for large gene transduction.
In a study published in Cell on Jan. 27, Prof. LU Zhonghua's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, and collaborators from Peking University First ...
Treatment initiation is possible with a positive liquid biopsy in primary central nervous lymphoma patients with difficult-to-access lesions
2026-01-28
Niigata, Japan – A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ten primary central nervous system lymphoma (PCNSL) patients who had difficult-to-access lesions in or around the brainstem, or were too frail to receive surgical biopsies. Hotspot MYD88 L265P mutations were detected from circulating tumor DNA (ctDNA) of cerebrospinal fluid (CSF) collected from lumbar taps in all patients.
A team led by Dr. Manabu Natsumeda successfully treated the patients after diagnosis by ...
Artificial nighttime lighting is suppressing moth activity
2026-01-28
Moths move significantly less when exposed to artificial nighttime light, new research shows.
Moths’ attraction to artificial light, such as streetlights, is common knowledge and has been much studied. But, as many people will have observed, moths may also remain still if they land near a light, apparently “trapped”.
To understand this behaviour, University of Exeter researchers caught more than 800 moths from 23 species and exposed them to LED lights (of various colours and brightness) or to natural night conditions.
Moths were collected with light traps and butterfly nets on the Penryn ...